Try GOLD - Free

Street places hopes on H2, cautious on GST cut effect

Mint Mumbai

|

October 20, 2025

Early estimates show India Inc.'s topline may have grown just 5-6% in Sep quarter

- Mayur Bhalerao & Abhinaba Saha

India Inc.'s top executives expect earnings to pick up only in the second half of FY26, and a majority believes the Goods and Services Tax (GST) boost to consumption has been overestimated, Mint's fifth quarterly market survey found, at a time of domestic resilience amid global uncertainty.

Of 36 fund managers, chief executive officers (CEOs) and research heads surveyed between 10 and 15 October, around 83% of the respondents, including those from Kotak Securities and Emkay Global, expect the September-quarter earnings growth to remain moderate and broadly in line with projections. Policy-led momentum is likely to pick up only from the December quarter.

"Despite global headwinds, India's domestic growth remains resilient. FY26 will be stronger than FY25, and FY27 could see double-digit earnings growth supported by GST 2.0 reforms, government capex, and policy tailwinds," said Dhiraj Relli, managing director & chief executive officer, HDFC Securities. He expects Nifty 50 firms to post 6-7% profit growth this quarter (July-September), with valuations already pricing in nearly 20 times FY27 earnings.

Neeraj Chadawar, head of fundamental and quantitative research at Axis Securities, expects Nifty 50's revenue, operating income and net profit to rise 9%, 4.8% and 8%, respectively, year-on-year, led by telecom, industrials, and utilities in Q2. However, banks and FMCG firms could face margin pressure, with a broader recovery likely only in the second half, he said.

About 14% of the survey respondents foresee muted second-quarter earnings amid global volatility and rising costs, while just 3% expect a positive surprise driven by a good monsoon and fiscal support.

MORE STORIES FROM Mint Mumbai

Mint Mumbai

Mint Mumbai

Anju Dodiya creates disquieting worlds

Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'

time to read

5 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

English's place in history is not black and white

In 1784, two white men joined forces to establish an English school in Thanjavur, Tamil Nadu.

time to read

4 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

Rising costs force Indian firms to rewrite employee benefits

Indian companies are rethinking the benefits they offer their staff, such as healthcare, retiral plans, well-being perks, and leave, as they seek to control budgets while retaining top talent without compromising on employee experience.

time to read

3 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

A modern-day throwback to 'Malgudi Days'

Sita Bhaskar's latest novel revisits writer R.K. Narayan’s legacy to explore class, caste, and community in Mysuru

time to read

3 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

Rajasthan limits e-NAM 2.0 pilot amid snags; 1.0 to stay

The Centre restricted e-NAM 2.0 pilot to 10 mandis, including Tonk, Jodhpur and Sujangarh

time to read

3 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

IiAS puts Bhatia, IndiGo board under the scanner

Institutional Investor Advisory Services India Ltd (IiAS) has faulted IndiGo promoter and managing director (MD) Rahul Bhatia for not leading from the front when the airline is facing its most challenging operational episode, even as it has sought a review of the current board structure which allows him to nominate half of the board.

time to read

2 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

Govt’s insurance reform allows 100% FDI, composite licences

The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.

time to read

3 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

Novo Nordisk debuts Ozempic at ₹2,200 a week

Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.

time to read

3 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

CBDC safer option, stablecoins pose greater risk: RBI

Central bank digital currencies are a far safer option than stablecoins, which pose greater risks than their purported benefits, according to Reserve Bank of India (RBI) deputy governor T. Rabi Sankar.

time to read

2 mins

December 13, 2025

Mint Mumbai

Mint Mumbai

Sebi weighs easier unified penalty rules for listed cos

Explores framework like the one for brokers that standardized and reduced fines

time to read

3 mins

December 13, 2025

Listen

Translate

Share

-
+

Change font size